We are 40% down again from initial raise of .75, lets see if directors buy something. Now financials are out as well so nothing is stopping them. DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025